(37) in GC cell line SGC7901, where the enhanced proliferation and migration ability induced by the glycolytic enzyme alpha-enolase (ENO1) overexpression was impaired after incubation with PI3K inhibitor LY294002. Here, ENO1 is linked to gastric cancer.